Every state in Brazil is now on alert.
No coração do inverno brasileiro, os mais frágeis — bebês e idosos — enfrentam uma onda de doenças respiratórias graves que lembra à sociedade sua responsabilidade coletiva com os vulneráveis. O vírus sincicial respiratório avança entre crianças menores de dois anos em dez estados de alto risco, enquanto a Influenza A ceifa vidas entre os mais velhos com uma letalidade desproporcional. Diante de 2.660 mortes registradas em 2026 e de uma curva ascendente em quatorze estados, as autoridades de saúde reafirmam que a vacinação não é apenas uma escolha individual, mas um ato de proteção comunitária.
- Hospitais em todo o Brasil registram aumento alarmante de bebês internados com síndrome respiratória aguda grave, com o VSR confirmado em 41,5% dos casos recentes.
- Dez estados já estão classificados como zonas de alto risco, e outros quatorze apresentam tendência de alta — o surto ainda não atingiu seu pico.
- A Influenza A, embora menos prevalente nos casos, é responsável por mais da metade das mortes confirmadas por SRAG em 2026, atingindo desproporcionalmente os idosos.
- O sistema de saúde oferece vacinas contra gripe e VSR, além de anticorpos monoclonais para prematuros, mas a cobertura precisa alcançar os grupos prioritários antes que a pressão sobre os hospitais se torne insustentável.
- A OPAS alertou no fim de abril que o Hemisfério Sul entrava na temporada de pico de vírus respiratórios — e os dados brasileiros confirmam que o aviso chegou a tempo, mas a janela de ação está se fechando.
O Brasil enfrenta um aumento expressivo de casos graves de síndrome respiratória aguda grave entre crianças menores de dois anos. O principal responsável é o vírus sincicial respiratório, o VSR, que inflama as pequenas vias aéreas dos pulmões — condição conhecida como bronquiolite — e foi identificado em 41,5% dos casos confirmados nas últimas quatro semanas.
O surto não atinge o país de forma uniforme. Dez estados estão classificados como zonas de alto risco, distribuídos entre o Norte, o Centro-Oeste, o Sudeste e o Nordeste. Em outros quatorze estados, os casos seguem em trajetória ascendente, indicando que o pior ainda está por vir. Todo o território nacional está em alerta.
A Influenza A apresenta um perfil distinto: representa 27,2% dos casos recentes, mas é responsável por 51,7% das mortes laboratorialmente confirmadas por SRAG em 2026 — mais da metade dos óbitos. Suas vítimas fatais se concentram entre os idosos, e o vírus avança rapidamente nos estados do Sul, em Roraima, Tocantins, São Paulo e Espírito Santo. No total, o Brasil já registrou 57.585 casos de SRAG e 2.660 mortes este ano.
Diante desse cenário, as autoridades de saúde reforçam a vacinação como principal estratégia de defesa. A pesquisadora Tatiana Portella, da Fiocruz, destacou que a imunização é essencial para evitar casos graves e mortes. O sistema público oferece vacina contra gripe para grupos prioritários — idosos, gestantes, crianças e pessoas com doenças crônicas — e vacina contra VSR para gestantes a partir da 28ª semana, protegendo o bebê após o nascimento por meio de anticorpos maternos. Para prematuros com maior risco, estão disponíveis anticorpos monoclonais, que oferecem proteção imediata.
Com a chegada do inverno, quando os vírus respiratórios circulam com mais intensidade, hospitais pediátricos e geriátricos enfrentam pressão simultânea. As próximas semanas serão decisivas para avaliar se as campanhas de vacinação conseguirão conter o avanço antes que mais vidas sejam perdidas.
Across Brazil, hospitals are seeing a sharp rise in severe respiratory illness among the youngest patients. Infants under two years old are arriving with acute respiratory syndrome—SRAG, in the medical shorthand—at rates that have alarmed public health officials. The culprit is the respiratory syncytial virus, or RSV, a pathogen that inflames the small airways deep in the lungs, a condition called bronchiolitis. In the past four weeks alone, RSV has been confirmed in 41.5 percent of all SRAG cases where a virus was identified, making it the dominant threat to Brazil's most vulnerable infants.
The outbreak is not uniform across the country. Ten states are now classified as high-risk zones: Acre, Amazonas, Pará, and Tocantins in the north; Mato Grosso, Goiás, Distrito Federal, and Mato Grosso do Sul in the center-west; Minas Gerais in the southeast; and Paraíba in the northeast. In fourteen additional states—stretching from the Amazon to the southern border—cases are trending upward, suggesting the surge will intensify in the coming weeks. Every state in Brazil is now on alert.
Influenza A tells a different story. While it accounts for only 27.2 percent of confirmed SRAG cases in recent weeks, it is far deadlier. Among the 1,151 laboratory-confirmed deaths from SRAG recorded so far in 2026, influenza A was responsible for 51.7 percent—more than half. These deaths cluster among the elderly, who face a steeper cliff when the virus takes hold. Influenza A is spreading rapidly in the three southern states, in Roraima and Tocantins to the north, and in São Paulo and Espírito Santo to the southeast. The Pan American Health Organization warned at the end of April that the Southern Hemisphere was entering peak season for respiratory viruses, with influenza A H3N2 and RSV leading the charge.
The numbers are substantial. Brazil has recorded 57,585 cases of SRAG in 2026 so far, with 45.7 percent testing positive for a respiratory virus. Across the full year, rhinovirus has been the most common culprit overall, present in 36.1 percent of samples, followed by influenza A at 26.3 percent and RSV at 25.3 percent. But when people die, the hierarchy shifts. Of the 2,660 total SRAG deaths recorded this year, influenza A dominates the fatal cases, followed by COVID-19 at 26 percent, rhinovirus at 21.3 percent, and RSV at 6.4 percent.
Public health authorities are emphasizing vaccination as the primary defense. Tatiana Portella, a researcher with the InfoGripe bulletin and the Fiocruz scientific computing program, stressed that immunization is essential to prevent severe illness and death from both RSV and influenza A. The national health system offers a flu vaccine that protects against influenza A, with priority given to elderly people, pregnant women, children under six, and those with chronic conditions or other vulnerabilities. A separate RSV vaccine is now available for pregnant women starting at twenty-eight weeks of gestation, designed to protect infants after birth through maternal antibodies. For premature infants at highest risk of severe RSV disease, the health system provides a monoclonal antibody—ready-made immune proteins that offer immediate protection, unlike a vaccine which trains the body to produce its own defenses.
The outbreak arrives as Brazil enters its winter months, when respiratory viruses circulate most freely. Hospitals in affected states are bracing for continued pressure. The convergence of two major threats—RSV in infants and influenza A in the elderly—means that pediatric and geriatric wards across the country are simultaneously stretched. The coming weeks will test whether vaccination campaigns can slow the spread before more children and elderly people fall ill.
Notable Quotes
The primary form of prevention against severe illness and death from RSV and influenza A is vaccination. It is essential that people at higher risk of severe disease from these viruses get vaccinated.— Tatiana Portella, researcher, InfoGripe bulletin and Fiocruz
The Hearth Conversation Another angle on the story
Why is RSV hitting infants so hard right now, when it's been around for decades?
RSV doesn't care about decades. It circulates every winter in the Southern Hemisphere, and infants have no immunity to it yet. Their lungs are still developing, and the virus inflames the smallest airways—the bronchioles—which can make breathing very difficult very quickly. The timing matters too: we're entering peak season.
But the data shows influenza A is actually killing more people. Why isn't that the headline?
Because the headline is about infants, and RSV is the infant crisis. Influenza A is deadlier overall, but it's killing mostly elderly people. Two different populations, two different stories happening at the same time. That's what makes this moment so tense—the health system has to manage both surges.
Ten states at high risk sounds like a lot. Is this a regional problem or a national one?
It's both. Ten states are in the red zone, but fourteen more are trending upward. Every single state is on alert. So while the crisis is most acute in places like Amazonas and Minas Gerais right now, nowhere in Brazil is safe from this.
The monoclonal antibody for premature infants—how does that work differently from a vaccine?
A vaccine teaches your immune system to fight the virus. An antibody is the finished product—it's like giving the baby the weapons directly, ready to use immediately. For a premature infant who might not have time to mount their own immune response, that immediate protection can be lifesaving.
What happens if vaccination rates don't go up?
Then you see what's already happening: more infants hospitalized, more elderly people dying, more pressure on hospitals that are already stretched. The window to prevent severe illness is narrow. Once the virus takes hold in the lungs, the vaccine can't help anymore.